5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Obesity is a global health crisis with detrimental effects on all organ systems leading to worsening disease state and rising costs of care. Persons with obesity failing lifestyle therapies need to be escalated to appropriate pharmacological treatment modalities, medical devices, and/or bariatric surgery if criteria are met and more aggressive intervention is needed. The progression of severe obesity in the patient population coupled with related co-morbidities necessitates the development of novel therapies for the treatment of obesity. This development is preceded by increased understanding of the underpinnings of energy regulation and neurohormonal pathways involved in energy homeostasis.

          Related collections

          Author and article information

          Journal
          Curr Obes Rep
          Current obesity reports
          Springer Nature
          2162-4968
          2162-4968
          Jun 2018
          : 7
          : 2
          Affiliations
          [1 ] Department of Medicine, Section of Endocrinology, Diabetes, Nutrition and Weight Management, Boston University School of Medicine, 720 Harrison Avenue, 8th Floor, Suite 801, Boston, MA, 02118, USA.
          [2 ] Department of Medicine, Section of Endocrinology, Diabetes, Nutrition and Weight Management, Boston University School of Medicine, 720 Harrison Avenue, 8th Floor, Suite 801, Boston, MA, 02118, USA. caroline.apovian@bmc.org.
          Article
          10.1007/s13679-018-0300-4
          10.1007/s13679-018-0300-4
          29504049
          2da70c52-bf22-47df-93b5-5c955663621f
          History

          Novel targets,Weight loss medications,Weight management,Phase 1 and phase 2 trials,Obesity pharmacotherapy,Anti-obesity drugs

          Comments

          Comment on this article